Atlas Trials

A Retrospective Immunohistochemistry Study of the Expression of Glycine/ Serine Pathway Molecules in Solid Tumors

Clinical trial NCT02103920 · UNKNOWN

Trial details

NCT number
NCT02103920
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Study type
OBSERVATIONAL
Solid Tumor Cancer
Start date
2011-05-01
Primary completion
2014-06-01
Enrollment
1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.